Sonoma Pharmaceuticals, Inc. Common Stock
SNOA Real Time Price USDRecent trades of SNOA by members of U.S. Congress
|
Name
|
Type
|
Shares
|
Price
|
Shares Held
|
Date
|
Reported
|
|---|
|
Investor
|
Shares
|
Change in Shares
|
Market Value
|
Date
|
Reported
|
|---|
|
Investor
|
Type
|
Shares
|
Change in Shares
|
Market Value
|
Date
|
Reported
|
|---|
Recently reported changes by institutional investors
Quarterly net insider trading by SNOA's directors and management
Government lobbying spending instances
Estimated quarterly lobbying spending
New patents grants
-
Patent Title: Stabilized hypochlorous acid solution and use thereof Sep. 17, 2019
-
Patent Title: Solution containing hypochlorous acid and methods of using same Jul. 09, 2019
-
Patent Title: Hydrogel formulation comprising oxidative reductive potential water Apr. 23, 2019
-
Patent Title: Method of preventing or treating influenza with oxidative reductive potential water solution Jul. 10, 2018
-
Patent Title: Stabilized hypochlorous acid solution and use thereof Mar. 20, 2018
-
Patent Title: Methods of treating or preventing inflammation and hypersensitivity with oxidative reductive potential water solution Oct. 10, 2017
-
Patent Title: Method of preventing or treating sinusitis with oxidative reductive potential water solution May. 09, 2017
Federal grants, loans, and purchases
Estimated quarterly amount awarded from public contracts
Number of mentions of SNOA in WallStreetBets Daily Discussion
Recent insights relating to SNOA
Recent picks made for SNOA stock on CNBC
ETFs with the largest estimated holdings in SNOA
The Quiver Smart Score combines our data on Congress Trading, Lobbying, Insider Trading, CNBC Mentions and more to provide a comprehensive view of the strength of a stock's underlying data.
The Smart Score grades stocks on a scale of 1 (weakest) to 10 (strongest) based on the strength of the underlying data.Sign Up to view SNOA Smart Score
See concise summaries of analyst reports, presenting both bullish and bearish arguments for a stock.
Example:
The Bulls Say summary highlights positive aspects of the stock.
The Bears Say summary points out potential risks and negative aspects of the stock.